logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Neoplasia in childhood : 25 years of progress. Discussion.

    Article, Communication - En anglais

    Recent advances in the biology and treatment of solid tumours. Symposium. Birmingham GBR, 1994/10/07.

    Background :

    Several factors have contributed to the improved prognosis for the survival and quality of life of children with cancer.

    Childhood tumours tend to have their origin in intrinsic genetic abnormalities, and are usually disseminated by the time of diagnosis.

    As a result, conventional treatments, such as ablative surgery and/or radiotherapy are rarely successful.

    The finding of specific genetic mutations underlying many childhood tumours may now provide an'Achilles heel'to enable the development of highly specific therapies that are relatively non-toxic to the normal tissues undergoing rapid growth and development during childhood.

    The rarity of childhood cancer and the need for multidisciplinary management make it impossible for the ordinary district hospital to deliver optimal treatment, though'maintenance'treatment and follow-up can be delivered locally as part of'shared care'with a regional centre.

    These centres are members of the U.K. Children's Cancer Study Group which was formed in 1977 and now treats 75% of all cases of childhood malignancy, with sufficient numbers to run randomized clinical trials for most tumour types, often in collaboration with other national paediatric oncology groups in Europe and the U.S.A. Conclusion : Children with cancer are likely to be major beneficiaries from the recent advances in the understanding of neoplasia, many of which stem from work on paediatric malignancies.

    Mots-clés Pascal : Tumeur maligne, Hémopathie maligne, Tumeur solide, Leucémie, Lymphome, Enfant, Homme, Incidence, Epidémiologie, Royaume Uni, Europe

    Mots-clés Pascal anglais : Malignant tumor, Malignant hemopathy, Solid tumor, Leukemia, Lymphoma, Child, Human, Incidence, Epidemiology, United Kingdom, Europe

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0569592

    Code Inist : 002B04B. Création : 01/03/1996.